Rhizomes as Multi-Target Pharmacological Platforms Against Tauopathy: Neuro-Metabolic Crosstalk, Drug-Likeness, and Translational Challenges. [PDF]
Setiawan AW +9 more
europepmc +1 more source
Deciphering Freezing of Gait: What Neuropathology Reveals About an Episodic Phenomenon
Freezing of gait (FoG) occurs across Parkinson's disease, multiple neurodegenerative conditions and non‐neurodegenerative disorders. This review synthesizes the structural, neurochemical and proteinopathic substrates underlying FoG, showing how cumulative damage to distributed locomotor circuits—compounded by overlapping pathologies—progressively ...
Gabor G. Kovacs
wiley +1 more source
Modification of early behavioural, physiological and neuropathological endpoints by syntaxin-6 knockout in a humanised P301S transgenic model of tauopathy. [PDF]
Hill E +15 more
europepmc +1 more source
Clinicopathological features of primary tauopathies: a brain bank series. [PDF]
Ryan B +5 more
europepmc +1 more source
An Integrative Proteomic Approach to Reveal Altered Signaling Modules During Alzheimer's Disease Progression in PS19 Tauopathy Mice. [PDF]
Cho E +7 more
europepmc +1 more source
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterised by progressive muscle weakness in both bulbar and extremity muscles, leading to a diverse clinical phenotype with motor and non‐motor symptoms. Cerebrospinal fluid (CSF) from sporadic ALS patients were analysed for proteomics content and revealed altered inflammatory and ...
Eleonora Sabetta +8 more
wiley +1 more source
Inhibition of beta-arrestin oligomerization in tauopathy
As disclosed herein, β-arrestin1 and β-arrestin2 levels are highly elevated in brains of FTLD-tau patients suggesting that both β-arrestin1 and β-arrestin2 are elevated in the brains of patients with AD and FLTD. The current work also shows that when
Woo, Jung A. +4 more
core
Mass spectrometry-based proteomic profiling of human tauopathy brains suggests mitochondria-associated alterations. [PDF]
Jannah AR +14 more
europepmc +1 more source
AAIC 2026 to kick off July 12 in London, United Kingdom, and online
Alzheimer's &Dementia, Volume 22, Issue 6, June 2026.
wiley +1 more source
Graphical summary of post‐mortem brain tissue findings that differ between symptomatic and asymptomatic AD. Current evidence suggests reduced accumulation of Aβ and p‐tau oligomers, particularly at synapses, preserved neuronal and synaptic integrity and metabolic activity and a dynamic profile of glial and immune responses in ASYMAD.
Thiago Guilherme Rêgo Barros +6 more
wiley +1 more source

